These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9524098)

  • 1. Unexpected in vitro chemosensitivity of malignant gliomas to 4-hydroxyperoxycyclophosphamide (4-HC).
    Recht LD; Glantz MJ; Meitner P; Glantz L; Akerley W; Wahlberg L; Saris S; Cole BF
    J Neurooncol; 1998 Feb; 36(3):201-8. PubMed ID: 9524098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
    Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells.
    Croix BS; Rak JW; Kapitain S; Sheehan C; Graham CH; Kerbel RS
    J Natl Cancer Inst; 1996 Sep; 88(18):1285-96. PubMed ID: 8797768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitivity of malignant human brain tumors. Preliminary results.
    Bogdahn U
    J Neurooncol; 1983; 1(2):149-66. PubMed ID: 6088712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential chemosensitivity in human intracerebral gliomas measured by flow cytometric DNA analysis.
    Iwadate Y; Fujimoto S; Yamaura A
    Int J Mol Med; 2002 Aug; 10(2):187-92. PubMed ID: 12119557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
    Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
    J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of in vitro chemosensitivity of perioperative human ovarian malignancies by adenosine triphosphate chemosensitivity assay.
    Gerhardt RT; Perras JP; Sevin BU; Petru E; Ramos R; Guerra L; Averette HE
    Am J Obstet Gynecol; 1991 Aug; 165(2):245-55. PubMed ID: 1872324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas.
    Iwadate Y; Fujimoto S; Tagawa M; Namba H; Sueyoshi K; Hirose M; Sakiyama S
    Int J Cancer; 1996 Jun; 69(3):236-40. PubMed ID: 8682593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay.
    Jordan JP; Hand CM; Markowitz RS; Black P
    J Neurooncol; 1992 Sep; 14(1):19-35. PubMed ID: 1335043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
    Pyrko P; Schönthal AH; Hofman FM; Chen TC; Lee AS
    Cancer Res; 2007 Oct; 67(20):9809-16. PubMed ID: 17942911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model.
    Sipos EP; Witham TF; Ratan R; Burger PC; Baraban J; Li KW; Piantadosi S; Brem H
    Neurosurgery; 2001 Feb; 48(2):392-400. PubMed ID: 11220384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can in-vitro chemoresponse assays help find new treatment regimens for malignant gliomas?
    Linz U; Ulus B; Neuloh G; Clusmann H; Oertel M; Nolte K; Weis J; Heussen N; Gilsbach JM
    Anticancer Drugs; 2014 Apr; 25(4):375-84. PubMed ID: 24423983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitro.
    Untch M; Sevin BU; Perras JP; Angioli R; Baibl A; Nguyen HN; Hightower RD; Averette HE
    Gynecol Oncol; 1992 Nov; 47(2):172-8. PubMed ID: 1468695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer.
    Sevin BU; Perras JP
    Am J Obstet Gynecol; 1997 Apr; 176(4):759-66; discussion 766-8. PubMed ID: 9125599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
    J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT; Sevin BU
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitivity testing of human gliomas using a fluorescent microcarrier technique.
    Bowles AP; Pantazis CG; Wansley W; Allen MB
    J Neurooncol; 1990 Apr; 8(2):103-12. PubMed ID: 2358844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on sensitivity of neuroglioma to chemotherapeutic drugs].
    Jiang S; Yuan S; Wang Y; Chen X; Song Y; Yang Y; Mao B
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):191-2, 232. PubMed ID: 12515133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro drug sensitivity testing in human gliomas.
    Kimmel DW; Shapiro JR; Shapiro WR
    J Neurosurg; 1987 Feb; 66(2):161-71. PubMed ID: 3543252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.